HOOKIPA Pharma Inc.
General ticker "HOOK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.0M (TTM average)
HOOKIPA Pharma Inc. does not follow the US Stock Market performance with the rate: -8.9%.
Estimated limits based on current volatility of 1.5%: low 0.85$, high 0.88$
Factors to consider:
- Total employees count: 82 (-45.7%) as of 2024
- Top business risk factors: Regulatory and compliance, Cybersecurity threats, Strategic risks and growth management, Management distraction, Intellectual property risks
- Current price 32.9% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.29$, 4.37$]
- 2025-12-31 to 2026-12-31 estimated range: [1.13$, 3.59$]
Financial Metrics affecting the HOOK estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -308.50 <= 0.33
- Positive: -4.48 < Investing cash flow per share per price, % of -0.78
- Positive: 41.86 < Shareholder equity ratio, % of 62.04 <= 63.39
Short-term HOOK quotes
Long-term HOOK plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $14.25MM | $20.13MM | $43.95MM |
| Operating Expenses | $87.40MM | $117.82MM | $95.40MM |
| Operating Income | $-73.16MM | $-97.69MM | $-51.45MM |
| Non-Operating Income | $8.47MM | $16.48MM | $7.85MM |
| Interest Expense | $0.69MM | $0.32MM | $0.00MM |
| R&D Expense | $68.64MM | $86.42MM | $68.51MM |
| Income(Loss) | $-64.69MM | $-81.21MM | $-43.61MM |
| Taxes | $0.23MM | $0.37MM | $-0.11MM |
| Profit(Loss)* | $-64.92MM | $-81.58MM | $-43.50MM |
| Stockholders Equity | $102.52MM | $89.86MM | $51.21MM |
| Inventory | $0.42MM | $0.00MM | $0.00MM |
| Assets | $170.45MM | $161.34MM | $82.55MM |
| Operating Cash Flow | $-20.00MM | $-57.52MM | $-76.98MM |
| Capital expenditure | $5.02MM | $4.16MM | $0.19MM |
| Investing Cash Flow | $-5.02MM | $-4.16MM | $-0.19MM |
| Financing Cash Flow | $72.27MM | $65.67MM | $-1.28MM |
| Earnings Per Share** | $-9.91 | $-8.63 | $-3.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.